{"id":"cardiolrx","safety":{"commonSideEffects":[{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Arrhythmias"},{"rate":null,"effect":"Hypotension"}]},"_chembl":null,"_fixedAt":"2026-03-30T13:34:41.104684","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CardiolRx utilizes exosome-based technology derived from mesenchymal stem cells to deliver therapeutic cargo that promotes cardiac tissue repair, reduces inflammation, and improves ventricular function. The mechanism involves modulation of the cardiac microenvironment to support regeneration and reduce fibrosis following acute myocardial infarction or heart failure.","oneSentence":"CardiolRx is a cardiac-regenerative therapy designed to repair and restore heart function following myocardial injury.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:05:01.066Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction with reduced ejection fraction"},{"name":"Heart failure with reduced ejection fraction"}]},"_fixedFields":["pubmed(1)"],"trialDetails":[{"nctId":"NCT06708299","phase":"PHASE3","title":"CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)","status":"RECRUITING","sponsor":"Cardiol Therapeutics Inc.","startDate":"2025-04-07","conditions":"Recurrent Pericarditis","enrollment":110},{"nctId":"NCT05494788","phase":"PHASE2","title":"Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)","status":"COMPLETED","sponsor":"Cardiol Therapeutics Inc.","startDate":"2023-01-09","conditions":"Recurrent Pericarditis","enrollment":27},{"nctId":"NCT04615949","phase":"PHASE2, PHASE3","title":"Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors","status":"TERMINATED","sponsor":"Cardiol Therapeutics Inc.","startDate":"2021-04-30","conditions":"COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor","enrollment":90},{"nctId":"NCT05180240","phase":"PHASE2","title":"Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis","status":"COMPLETED","sponsor":"Cardiol Therapeutics Inc.","startDate":"2022-06-22","conditions":"Acute Myocarditis","enrollment":109}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"recentPublications":[{"date":"2006","pmid":"30601607","title":"Cannabidiol.","journal":""}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cannabidiol","Pharmaceutically produced Cannabidiol","Pharmaceutically produced cannabidiol"],"phase":"phase_3","status":"active","brandName":"CardiolRx","genericName":"CardiolRx","companyName":"Cardiol Therapeutics Inc.","companyId":"cardiol-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CardiolRx is a cardiac-regenerative therapy designed to repair and restore heart function following myocardial injury. Used for Acute myocardial infarction with reduced ejection fraction, Heart failure with reduced ejection fraction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}